These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7966942)

  • 21. Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells.
    Brock TA; Dvorak HF; Senger DR
    Am J Pathol; 1991 Jan; 138(1):213-21. PubMed ID: 1987767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. von Willebrand factor in cultured human vascular endothelial cells from adult and umbilical cord arteries and veins.
    van Wachem PB; Reinders JH; van Buul-Wortelboer MF; de Groot PG; van Aken WG; van Mourik JA
    Thromb Haemost; 1986 Oct; 56(2):189-92. PubMed ID: 3492775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Investigation of von Willebrand-factor as a marker of endothelial dysfunction in atherosclerotic patients].
    Horváth B; Hegedüs D; Szapáry L; Márton Z; Alexy T; Koltai K; Gyevnár Z; Juricskay I; Tóth K; Késmárky G
    Orv Hetil; 2003 Dec; 144(50):2471-6. PubMed ID: 15067986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia potentiates nitric oxide synthesis and transiently increases cytosolic calcium levels in pulmonary artery endothelial cells.
    Hampl V; Cornfield DN; Cowan NJ; Archer SL
    Eur Respir J; 1995 Apr; 8(4):515-22. PubMed ID: 7664847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of factor VIII von Willebrand factor in endothelial cells in first-trimester fetuses.
    Travis PA; Bovill EG; Hamill B; Tindle BH
    Arch Pathol Lab Med; 1988 Jan; 112(1):40-2. PubMed ID: 2447849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. von Willebrand factor: a marker of endothelial damage?
    Mannucci PM
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1359-62. PubMed ID: 9743222
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanisms of endothelial dysfunction during aging: Predisposition to thrombosis.
    Sepúlveda C; Palomo I; Fuentes E
    Mech Ageing Dev; 2017 Jun; 164():91-99. PubMed ID: 28477984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels.
    Albornoz L; Alvarez D; Otaso JC; Gadano A; Salviú J; Gerona S; Sorroche P; Villamil A; Mastai R
    J Hepatol; 1999 Mar; 30(3):451-5. PubMed ID: 10190728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polar secretion of von Willebrand factor by endothelial cells.
    van Buul-Wortelboer MF; Brinkman HJ; Reinders JH; van Aken WG; van Mourik JA
    Biochim Biophys Acta; 1989 May; 1011(2-3):129-33. PubMed ID: 2785404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monocytes enhance endothelial von Willebrand factor release and prostacyclin production with different kinetics and dependency on intercellular contact between these two cell types.
    Hakkert BC; Rentenaar JM; van Mourik JA
    Br J Haematol; 1992 Apr; 80(4):495-503. PubMed ID: 1581234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential regulation of von Willebrand factor exocytosis and prostacyclin synthesis in electropermeabilized endothelial cell monolayers.
    Frearson JA; Harrison P; Scrutton MC; Pearson JD
    Biochem J; 1995 Jul; 309 ( Pt 2)(Pt 2):473-9. PubMed ID: 7626011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The change of vWF in vascular endothelial cells under different stress].
    Hong X; Li FZ; Yin ZY; Yan PH; He YX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2000 Nov; 16(4):310-3. PubMed ID: 11236684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. von Willebrand factor and its relevance to cardiovascular disorders.
    Lip GY; Blann AD
    Br Heart J; 1995 Dec; 74(6):580-3. PubMed ID: 8541159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of von Willebrand factor secretion in different human endothelial hybrid cell lines.
    Hohenwarter O; Schmatz C; Katinger H
    Cytotechnology; 1992; 8(1):31-7. PubMed ID: 1368401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial cell damage and homocysteine.
    Blann AD
    Atherosclerosis; 1992 May; 94(1):89-91. PubMed ID: 1632863
    [No Abstract]   [Full Text] [Related]  

  • 36. Venous occlusion does not release von Willebrand factor, factor VIII or PAI-1 from endothelial cells--the importance of consensus on the use of correction factors for haemoconcentration.
    Wieczorek I; Ludlam CA; MacGregor I
    Thromb Haemost; 1993 Jan; 69(1):91, 93. PubMed ID: 8446947
    [No Abstract]   [Full Text] [Related]  

  • 37. Differential effects of enzymatic treatments on the storage and secretion of von Willebrand factor by human endothelial cells.
    Lopes AA; Peranovich TM; Maeda NY; Bydlowski SP
    Thromb Res; 2001 Feb; 101(4):291-7. PubMed ID: 11248290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic immunoglobulin reduces Ca2+ mobilization and von Willebrand factor secretion, and increases nitric oxide release in human endothelial cells.
    David-Dufilho M; Schussler O; Pernollet MG; Brunet A; Millanvoye-Van Brussel E; Le Quan Sang KH; Rendu F
    Thromb Haemost; 2003 Dec; 90(6):1046-53. PubMed ID: 14652635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells.
    Schorer AE; Moldow CF; Rick ME
    Br J Haematol; 1987 Oct; 67(2):193-7. PubMed ID: 3499929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DDAVP-induced release of von Willebrand factor from endothelial cells in vitro: the effect of plasma and blood cells.
    Hashemi S; Tackaberry ES; Palmer DS; Rock G; Ganz PR
    Biochim Biophys Acta; 1990 Apr; 1052(1):63-70. PubMed ID: 2108732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.